Further, postprandial GLP-1 secretion in response to oral glucose ingestion is considerably attenuated in obese individuals compared with lean individuals [23], supporting the action of GLP-1 elevating drugs in combatting hyperglycemia. This evidence concerns the gene GCG and Hyperglycemia.